Moreover, MARC2 was significantly negatively correlated with activation of CD4+T cells and slightly negatively associated with Th1, Th2, and Th17 subsets, indicating that MARC2 downregulation in HCC patients was correlated with the differentiation of CD4+T cells into Tregs (Figure 3C). Here, MTARC2 is linked to hepatocellular carcinoma.